AiCure logo

AiCure Funding & Investors

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments. It enables intelligent decision-making and improving health outcomes. It has developed patented facial recognition and motion-sensing technology to confirm medication ingestion in real-time. AiCure's platform has the potential to revolutionize the cost-effectiveness of healthcare delivery systems by enhancing treatment and reducing risks. Their software captures and understands video, audio, and behavioral data to establish the link between patients, disease, and treatment. It was founded in 2010 and is headquartered in New York.

aicure.com

Total Amount Raised: $68,750,000

AiCure Funding Rounds

  • Grant

    $1,000,000

    Grant Investors

    National Institute on Drug Abuse (NIDA)
  • Series Unknown

    $4,000,000

  • Debt Financing

    $12,000,000

  • Series C

    $24,500,000

    Series C Investors

    Palisades Growth Capital
    Baird Capital
    Tribeca Venture Partners
    Pritzker Group Venture Capital
    Accelmed
    Biomatics Capital Partners
    First Citizens Bank
    Asahi Kasei
    SpringRock Ventures
    New Leaf Venture Partners
    Singtel Innov8
  • Series B

    $15,000,000

    Series B Investors

    Baird Capital
    New Leaf Venture Partners
    Pritzker Group Venture Capital
    Tribeca Venture Partners
    Biomatics Capital Partners
  • Series A

    $12,250,000

    Series A Investors

    New Leaf Venture Partners
    Pritzker Group Venture Capital
    Tribeca Venture Partners
    Biomatics Capital Partners
Funding info provided by Diffbot.